SCNI — Scinai Immunotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Scinai Immunotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	10-K
Standards:	IFRS	IFRS	IFRS	IFRS	USG
Status:	fx Final	fx Final	fx Final	fx Final	Final
Cash and Equivalents
Cash and Short Term Investments	20.3	21	2.93	17.4	14.1
Net Total Receivables	0.258	0.19	0.375	0.326	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	20.6	21.2	3.31	17.7	14.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.56	12.2	14.3	14.2	12.7
Other Long Term Assets
Total Assets	28.3	33.5	17.7	32.1	27.1
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	5.84	5.49	20	2.32	2.34
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	36.7	52.4	22.3	24.6	28.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-8.36	-18.8	-4.55	7.52	-1.76
Total Liabilities & Shareholders' Equity	28.3	33.5	17.7	32.1	27.1
Total Common Shares Outstanding